Background Aortic stenosis is a degenerative condition with high mortality in its severe stages and no preventive treatment.

In patients greater than age 65, more than 90% of aortic stenosis involves trileaflet valves which have developed heavy calcification. [5] In these instances the calcium deposits are thought to ...

Aortic stenosis, affecting nine million people globally, is often unnoticed as symptoms are mistaken for aging. This heart condition, common in elderly, restricts blood flow due to valve narrowing ...

February is American Heart Month. Sister Bay’s David Lienau wasn’t even aware that his heart health was in jeopardy. But ...

The Medicare data contradict results from the TCW randomized trial but better represent real-world practice, say authors.

"AISAP is proud to collaborate with forward-thinking practices and community partners like Amavita," said Roni Attali, AISAP ...

The Navitor Vision, Abbott's latest TAVI system, is designed to improve accuracy during implantation and enhance visibility ...

The Heart and Vascular center at Portneuf Medical Center recently marked its 400th transaortic valve replacement procedure.

Abbott introduces Navitor Vision in India, the next generation of heart valve technology designed to treat aortic stenosis: Our Bureau, Mumbai Thursday, January 30, 2025, 15:15 Hr ...

Myval THV matches SAPIEN and Evolut THVs in 30-day outcomes, supporting its role in severe aortic stenosis treatment.